Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
NCT06194851Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2024
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: PTSD diagnosis and severity change. Started Oct 2024; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06194851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06194851.